Pfizer Asserts 2nd Lyrica Patent Against Mylan
Pfizer Inc. has filed a second patent infringement suit against Australia-based drugmaker Alphapharm Pty. Ltd. and U.S. affiliate Mylan Pharmaceuticals Inc. over their efforts to market a generic version of nerve...To view the full article, register now.
Already a subscriber? Click here to view full article